Impedimed Limited has released a press release.
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-316
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- ImpediMed Secures Order from Large US Oncology Care Network
- New National Purchasing Agreement for Lymphoedema Prevention
- Baylor Scott & White Expands SOZO Use with New iOS Software
- Appendix 4D and Interim Financial Report (Signed)
- NCCN Guidelines for Breast Cancer Updated for Lymphoedema
Later from Impedimed
- Successful Completion of $10m Institutional Portion of Offer
- ImpediMed Releases Heart Failure and Renal Disease Software
- Appendix 4C - Quarter ended 31 March 2020
- Change in substantial holding
- Independent BIS RE-AIM Analysis to be Released at ASCO 2020
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed